Disabled-2 (Dab2; also known as p96 and DOC-2) is a signal transduction protein that has been implicated in the control of cell growth. Dab2 is known to be a phosphoprotein, but little is known about the kinases that phosphorylate Dab2. We have found that Dab2 phosphorylation is markedly increased during the mitosis phase of the cell cycle. This phosphorylation is blocked by roscovitine, a selective inhibitor of cyclin-dependent kinases. Dab2 robustly coimmunoprecipitates from cells with the cyclin-dependent kinase cdc2, and purified cdc2 can phosphorylate purified Dab2 fusion proteins in vitro on multiple sites. Cellular phosphorylation of Dab2 by cdc2 promotes the association of Dab2 with Pin1, a peptidylprolyl isomerase that regulates the rate of Dab2 dephosphorylation. These findings reveal that Dab2 is differentially phosphorylated during the cell cycle by cdc2 and provide a potential feedback mechanism by which Dab2 inhibition of cell growth and proliferation may be regulated.
Introduction
The Drosophila protein Disabled (Dab) was originally identified as the product of a gene with a key role in neural development (Gertler et al., 1989) . Mammals possess two Dab orthologs: Dab1, which is almost exclusively expressed in the brain (Howell et al., 1997a) , and Dab2 (also called p96 and DOC-2), which is expressed in many tissues (Mok et al., 1994; Xu et al., 1995; Albertsen et al., 1996) . Mutations to Dab1 underlie the abnormal brain development observed in the mutant strains of mice known as scrambler and yotari (Howell et al., 1997b; Sheldon et al., 1997; Ware et al., 1997) , suggesting a role for Dab1 in neural development similar to that of Drosophila Dab. In contrast, Dab2 plays no known role in neural development, but rather is considered a candidate tumor suppressor because it is downregulated in various types of tumor (Mok et al., 1994; Fulop et al., 1998; Fazili et al., 1999) and is capable of strongly inhibiting cell growth and proliferation in many cell types (Fulop et al., 1998; Mok et al., 1998; Tseng et al., 1999; Sheng et al., 2000; He et al., 2001b; Smith et al., 2001; Wang et al., 2001) .
The structure of Dab2 suggests that it may act as an adapter protein. Dab2 contains an amino-terminal phosphotyrosine-binding (PTB) domain, which has been shown to associate with transmembrane proteins such as the low-density lipoprotein receptor (Morris and Cooper, 2001 ) and transforming growth factor b receptors (Hocevar et al., 2001) , as well as with the Ras GAP DIP1/2 (Wang et al., 2002) . Additionally, Dab2 contains a carboxy-terminal proline-rich domain (PRD), which can associate with SH3 domain-containing proteins such as Grb2 (Xu et al., 1998; Zhou and Hsieh, 2001) . It has also recently been reported that the Dab2 carboxyl terminus can associate with myosin VI (Inoue et al., 2002; Morris et al., 2002) . The association of Dab2 with multiple signaling proteins and the lack of intrinsic Dab2 enzymatic activity point to a role for Dab2 as an adapter protein involved in organizing cellular signaling pathways involved in the regulation of cell growth.
Dab2 is known to be heavily phosphorylated in cells (Xu et al., 1995; Tseng et al., 1999) . This phosphorylation is known to occur exclusively on serine residues (Xu et al., 1995) , but the kinases mediating this phosphorylation have only been partially identified. One kinase that acts on Dab2 is protein kinase C (PKC), which can phosphorylate Dab2 on Ser24 (Tseng et al., 1999) . It is known that there are multiple other sites of Dab2 phosphorylation (Tseng et al., 1999) , but the kinase(s) mediating phosphorylation of these other sites have not been elucidated. Since Dab2 plays a key role in regulating cell growth and proliferation, we examined the state of Dab2 phosphorylation during the cell cycle. Our data indicate that Dab2 phosphorylation is profoundly enhanced during mitosis phase due to phosphorylation on multiple sites by the cyclin-dependent kinase cdc2.
Experimental procedures

Cell culture
All tissue culture media and related reagents were purchased from Gibco/Life Technologies. HeLa and COS-7 cells were maintained in complete medium (double minimal essential medium plus 10% fetal bovine serum and 1% penicillin/streptomycin) in a 371C/5% CO 2 incubator. HeLa cells were synchronized at the G1/ S phase boundary using the thymidine-aphidicolin double-block method, as described previously (He et al., 2001a) . Cells in S phase were obtained 3 h after release from the G1/S phase block. Mitosis and G2 phase cells were obtained following a 14-18 h treatment with nocodazole (50 ng/ml, Sigma), as described previously (He et al., 2001a) . The cell cycle state of the cells harvested following these various protocols was confirmed using flow cytometry, as described previously (He et al., 2001a) .
Preparation of fusion proteins
Three distinct regions of Dab2 were expressed as glutathione-S-transferase (GST) fusion proteins using the pGEX-2TK vector (Pharmacia). The phosphotyrosine interacting domain (PID, amino acids #1-233), middle region (M15, amino acids #335-610), and PRD (amino acids #600-730) of Dab2 were created by PCR using cDNA as a template and inserted into the pGEX-2TK vector. All sequences were confirmed by ABI sequencing. The construct for expressing GST-Pin1 was a generous gift from Michael Yaffe (Massachusetts Institute of Technology).
SDS-PAGE and Western blotting
Samples (5 mg/lane) were run on 4-20% SDS-polyacrylamide gels (SDS-PAGE) (Novex) for 1 h at 150 V, and then transferred to nitrocellulose. The blots were blocked in blot buffer (2% nonfat dry milk, 0.1% Tween 20, 50 mm NaCl, and 10 mm HEPES, pH 7.4) for at least 30 min and then incubated with primary antibody in blot buffer for 1 h at room temperature. The blots were washed three times with 10 ml of blot buffer and incubated for 1 h more at room temperature with a horseradish peroxidase-conjugated secondary antibody (Amersham Pharmacia Biotech) in blot buffer. Finally, the blots were washed three more times with 10 ml of blot buffer and visualized via enzyme-linked chemiluminescence (ECL) using the ECL kit from Amersham Pharmacia Biotech.
Pull-down assays
GST-PIN1 fusion proteins were purified on glutathione agarose beads, as described previously (He et al., 2001a) . Aliquots of the fusion protein/bead mixture in 1.5 ml microcentrifuge tubes were blocked for 1 h with 1 ml of a 3% BSA buffer (also containing 10 mm HEPES, 50 mm NaCl, and 0.1% Tween 20), and then incubated with cell lysates for 2 h. The beads were washed five times with ice-cold 3% BSA blocking buffer and washed once with harvest buffer. The proteins were eluted from the beads with 1 Â SDS-PAGE sample buffer, resolved via SDS-PAGE and transferred to nitrocellulose. Dab2 was detected via Western blotting with the anti-p96 antibody from Transduction Laboratories (1 : 2000), AP-2 was detected with the anti-AP-2 antibody from Transduction Laboratories (1 : 1000), and bands were visualized via chemiluminescence as described above.
Kinase assays
In vitro phosphorylation experiments were carried out at room temperature in a final volume of 25 ml with 10 mm HEPES, pH 7.4, 10 mm MgCl 2 , and 2 mm EDTA. In this buffer, purified fusion proteins (2 mg), either GST-PID, GST-M15 or GST-PRD, were incubated with purified recombinant human Cdc2/cyclin B (10 units, Calbiochem). Reactions were initiated via the addition of [g-32 P] ATP (1 mCi; Amersham Pharmacia Biotech) and were allowed to proceed for 30 min at room temperature before being stopped with SDS-PAGE sample buffer.
Phosphorylated samples were run on 4-20% SDS-PAGE, fixed, dried, and exposed to film. The extent of phosphorylation was quantified via the scanning of films followed by densitometric analysis of bands.
Immunoprecipitation
Cells were harvested and lysed in 500 ml of ice-cold lysis buffer (10 mm HEPES, 50 mm NaCl, 5 mm EDTA, 1 mm benzamidine, 0.5% Triton X-100). Lysates were solubilized via end-over-end rotation at 41C for 30 min and clarified via centrifugation at 14 000 r.p.m. for 15 min. A small fraction of the supernatant was taken at this point and incubated with SDS-PAGE sample buffer in order to examine expression of proteins in the whole cell extract. The remaining supernatant was incubated with 15 ml of anti-Cdc2 (Santa Cruz), anti-CDK5 (Santa Cruz) or anti-CDK2 (Upstate Biotechnology) for 2 h with end-over-end rotation at 41C before being incubated with Protein A/G agarose beads (Sigma) for 1 h. For the mock-immunoprecipitated sample, Protein A/G agarose beads were added in the absence of any antibody. Following the 1 h incubation, the beads were washed five times with 1.0 ml of lysis buffer, and immunoprecipitated proteins were eluted from the beads with 1 Â SDS-PAGE sample buffer, resolved by SDS-PAGE, and subjected to Western blot analysis with antiDab2 antibodies (Transduction Labs) or anti-AP-2 antibodies (Transduction Labs).
Results
Dab2 is hyperphosphorylated during mitosis phase
Phosphorylation of Dab2 is known to correlate with reduced mobility of Dab2 on SDS-PAGE (Xu et al., 1995; Tseng et al., 1999) . We performed Western blot analyses of Dab2 in HeLa cells that were synchronized and harvested at various points during the cell cycle. The SDS-PAGE mobility of Dab2 was consistent across all of the cell cycle phases except for mitosis phase, where the Dab2 polypeptide exhibited a striking decrease in electrophoretic mobility (Figure 1a ). This shift in the apparent size of Dab2 was reversed via treatment of the harvested lysates with alkaline phosphatase (data not shown), indicating that the shift is due to phosphorylation of Dab2. Moreover, the mitosisphase-dependent shift in Dab2 electrophoretic mobility was completely blocked by incubation of the cells with roscovitine, a specific inhibitor of cyclin-dependent kinases (Figure 1b ). Similar observations of the increased apparent size of Dab2 during mitosis phase and the blockade of this effect by roscovitine were made in COS-7 cells (data not shown). These data indicate that Dab2 is phosphorylated by cyclin-dependent kinases during mitosis phase.
Dab2 associates with and is phosphorylated by cdc2
In order to examine the specific cyclin-dependent kinase that might be responsible for the observed mitosis-phase phosphorylation of Dab2, coimmunoprecipitation experiments were performed. Interactions between cyclindependent kinases and their substrates are typically quite stable and can frequently be detected via coimmunoprecipitation (Endicott et al., 1999) . We immunoprecipitated three cyclin-dependent kinases from mitosis-phase HeLa cell lysates: cdc2 (CDK1), CDK2, and CDK5. Dab2 specifically coimmunoprecipitated with cdc2 but was not detectably coimmunoprecipitated with the other two kinases (Figure 2a ). Anticdc2 immunoprecipitates were also probed for AP-2, an unrelated protein that is abundant in HeLa cells and similar in size to Dab2. No AP-2 immunoreactivity could be detected in the cdc2 immunoprecipitates (Figure 2b ), demonstrating the specificity of the coimmunoprecipitation between Dab2 and cdc2. These data reveal that cdc2 specifically associates with Dab2 and suggest that cdc2 may be the kinase responsible for the observed phosphorylation of Dab2 during mitosis phase.
In vitro phosphorylation experiments with purified cdc2 and purified Dab2 fusion proteins were performed next to see if Dab2 is in fact a substrate for cdc2. As shown in Figure 3 , GST fusion proteins corresponding to the PTB and PRD domains of Dab2 were robustly phosphorylated by purified cdc2. In contrast, neither control GST nor a GST fusion protein corresponding to the middle portion of the Dab2 polypeptide, referred to as the M15 region (Xu et al., 1995) were detectably phosphorylated in these experiments. These findings indicate that cdc2 can phosphorylate Dab2 on multiple sites in two distinct domains of the Dab2 protein.
cdc2-phosphorylated Dab2 associates with Pin1
A number of signaling proteins are known to interact with the peptidylprolyl isomerase Pin1, following cdc2- (Lu et al., 2002) . We therefore examined the potential association of Dab2 with Pin1. Lysates from HeLa cells harvested during either interphase or mitosis were incubated with beads loaded with either GST or GST-Pin1. No Dab2 association with control GST was detected, nor was any Dab2 association with GST-Pin1 evident in the lysates derived from interphase HeLa cells. In contrast, Dab2 from mitosis-phase lysates was robustly pulled down by GST-Pin1 (Figure 4a ). GST-Pin1 failed to pull down any detectable AP-2 from the cell lysates (Figure 4b ), demonstrating the specificity of the interaction between Dab2 and Pin1. The association of Dab2 with Pin1 was blocked by treatment of mitosis-phase cells with roscovitine (Figure 4c ), suggesting that the Dab2/Pin1 interaction is dependent upon cdc2-mediated phosphorylation.
Dephosphorylation of Dab2 is dependent on Pin1 and PP1/PP2A
We next examined the dephosphorylation of Dab2. HeLa cells were reseeded after mitosis phase and examined via Western blot at various time points. Dab2 was progressively dephosphorylated over several hours, with 4 h being the time point at which full dephosphorylation was consistently observed (Figure 5a ). The half-life for the return of Dab2 to the dephosphorylated state was approximately 1.5 h, as shown in the quantification of the data presented in Figure 5b . This time frame corresponded well with the time it took for the cells to completely proceed through mitosis and exit mitosis phase, according to our own flow cytometry studies (data not shown) and the previous work of others on the exit of HeLa cells from nocodazole-induced blockade of mitosis (Zieve et al., 1980) . The dephosphorylation of Dab2 following exit from mitosis phase was completely blocked by incubation of the cells with juglone, an inhibitor of Pin1 peptidylprolyl isomerase activity (Figure 6a ). These data reveal a key role for Pin1 in regulating the dephosphorylation of cdc2-phosphorylated Dab2. Many substrates for cyclin-dependent kinases are dephosphorylated by protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) (Veeranna et al., 1995; Ajiro et al., 1996; Kwon et al., 1997; He et al., 2001a) , which explains in part why inhibitors of PP1 and PP2A are potent tumor promoters (Haystead et al., 1989; Suganuma et al., 1990) . We examined the abilities of the PP1/PP2A-selective inhibitor okadaic acid and the PP2B-selective inhibitor deltamethrin to block dephosphorylation of Dab2. As shown in Figure 6b , okadaic acid strongly inhibited Dab2 dephosphorylation following the end of mitosis phase, while deltamethrin had no significant effect on Dab2 postmitotic dephosphorylation. These data indicate that Dab2 is dephosphorylated following the end of mitosis phase by PP1 and/or PP2A, but not by PP2B.
Discussion
We have found that Dab2 is hyperphosphorylated in mitosis phase. We have also found that this phosphorylation is mediated by cdc2, a cyclin-dependent kinase that is known to be most active in mitosis phase (Kishimoto and Okumura, 1997) . The motif preferred for phosphorylation by cdc2 is a serine or threonine followed by a proline, with flanking residues playing a modulatory role (Holmes and Solomon, 1996; Endicott et al., 1999) . Analysis of the Dab2 polypeptide sequence reveals a number of serines that conform to the preferred cdc2 phosphorylation motif. Indeed, our data demonstrate that Dab2 can be phosphorylated on multiple sites by cdc2, since both the Dab2 PTB and PRD domains are excellent substrates for phosphorylation by purified cdc2.
The only kinase that has been previously reported to phosphorylate Dab2 is PKC, which phosphorylates Ser24 (Tseng et al., 1999) . This phosphorylation enhances the association of Dab2 with the Ras GAP Dip1/2 (Wang et al., 2002) . Interestingly, phosphorylation of Dab2 by cdc2 also promotes Dab2 association with another protein, the peptidylprolyl isomerase Pin1. A number of proteins that are phosphorylated by cdc2 have been shown to associate with Pin1 following phosphorylation (Lu et al., 2002) . Pin1 contains a WW domain that binds with high affinity to particular motifs dephosphorylation is mediated by PP1and/or PP2A. Mitotic HeLa cells were reseeded in six-well plates and then harvested after 4 h in the absence or presence of the PP1/PP2A-selective phosphatase inhibitor okadaic acid ('OA': 1 mm) or the PP2B-selective inhibitor deltamethrin ('Delt': 10 mm). Treatment with okadaic acid blocked Dab2 dephosphorylation, while deltamethrin had no effect, indicating that PP1 and/or PP2A are the phosphatases responsible for the observed dephosphorylation of Dab2. Molecular mass standards are shown on the left. All data shown in this figure are representative of at least three independent experiments containing proline residues and phosphorylated serines (Verdecia et al., 2000) . The association of some phosphoproteins with Pin1 has been found to regulate their rate of dephosphorylation, perhaps through Pin1-induced conformational changes that alter the accessibility of phosphorylated residues to phosphatases (Lu et al., 2002) . Our data reveal that the interaction between Dab2 and Pin1 facilitates Dab2 dephosphorylation. Moreover, this interaction may have other functional implications for Dab2, given the large number of proteins involved in the regulation of cell growth that are known to associate with Pin1.
Dab2 shares significant sequence homology with Dab1 (Howell et al., 1997a) . Mammalian Dab1 is known to be phosphorylated by the tyrosine kinase Src (Keshvara et al., 2001) and by the cyclin-dependent kinase cdk5 (Keshvara et al., 2002) . None of the identified Dab1 phosphorylation sites, however, are conserved in Dab2. Indeed, we found no evidence in our studies for Dab2 interaction with cdk5, although we did detect a robust physical association between Dab2 and cdc2. These findings suggest that Dab1 and Dab2 are phosphorylated by distinct cyclindependent kinases, perhaps reflecting the distinct roles of these two signaling proteins in regulating cellular processes.
Since Dab2 is a candidate tumor-suppressor gene product (Mok et al., 1994; Fulop et al., 1998; Fazili et al., 1999) and is known to inhibit cell growth and proliferation in various cell types (Fulop et al., 1998; Mok et al., 1998; Tseng et al., 1999; Sheng et al., 2000; He et al., 2001b; Smith et al., 2001; Wang et al., 2001) , the observation that its phosphorylation state and interactions with other proteins can change during the cell cycle is of interest. Cyclin-dependent kinases are known to phosphorylate many proteins that regulate the rate of progression through the cell cycle and exert reciprocal effects on cyclin-dependent kinase activity (Ferrell, 2002) . Along these lines, the cdc2-mediated phosphorylation of Dab2 described here may represent a feedback mechanism by which the effects of Dab2 on cell growth may be regulated during the cell cycle.
